Search details
1.
An Oncogenic Alteration Creates a Microenvironment that Promotes Tumor Progression by Conferring a Metabolic Advantage to Regulatory T Cells.
Immunity
; 53(1): 187-203.e8, 2020 07 14.
Article
in English
| MEDLINE | ID: mdl-32640259
2.
A phase 1 trial of NY-ESO-1-specific TCR-engineered T-cell therapy combined with a lymph node-targeting nanoparticulate peptide vaccine for the treatment of advanced soft tissue sarcoma.
Int J Cancer
; 152(12): 2554-2566, 2023 06 15.
Article
in English
| MEDLINE | ID: mdl-36727538
3.
Density and maturity of peritumoral tertiary lymphoid structures in oesophageal squamous cell carcinoma predicts patient survival and response to immune checkpoint inhibitors.
Br J Cancer
; 128(12): 2175-2185, 2023 06.
Article
in English
| MEDLINE | ID: mdl-37016103
4.
Effect of Low-Density Lipoprotein Apheresis on Quality of Life in Patients with Diabetes, Proteinuria, and Hypercholesterolemia.
Blood Purif
; 52(4): 373-381, 2023.
Article
in English
| MEDLINE | ID: mdl-36521435
5.
Prognostic significance of NY-ESO-1 antigen and PIGR expression in esophageal tumors of CHP-NY-ESO-1-vaccinated patients as adjuvant therapy.
Cancer Immunol Immunother
; 71(11): 2743-2755, 2022 Nov.
Article
in English
| MEDLINE | ID: mdl-35429246
6.
PD-1+ regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer.
Proc Natl Acad Sci U S A
; 116(20): 9999-10008, 2019 05 14.
Article
in English
| MEDLINE | ID: mdl-31028147
7.
Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk: Meta-Analysis of 119 Clinical Trials Involving 100 667 Patients.
Circulation
; 142(7): 621-642, 2020 08 18.
Article
in English
| MEDLINE | ID: mdl-32546049
8.
Safety and antibody immune response of CHP-NY-ESO-1 vaccine combined with poly-ICLC in advanced or recurrent esophageal cancer patients.
Cancer Immunol Immunother
; 70(11): 3081-3091, 2021 Nov.
Article
in English
| MEDLINE | ID: mdl-33751208
9.
The impact of ICOS+ regulatory T cells and Helicobacter pylori infection on the prognosis of patients with gastric and colorectal cancer: potential prognostic benefit of pre-operative eradication therapy.
Cancer Immunol Immunother
; 70(2): 443-452, 2021 Feb.
Article
in English
| MEDLINE | ID: mdl-32803278
10.
Effects of LDL apheresis on proteinuria in patients with diabetes mellitus, severe proteinuria, and dyslipidemia.
Clin Exp Nephrol
; 25(1): 1-8, 2021 Jan.
Article
in English
| MEDLINE | ID: mdl-32857255
11.
[Practical Basis of Immunohistochemical Research and Multiplexed Immunohistochemistry].
Gan To Kagaku Ryoho
; 48(3): 320-324, 2021 Mar.
Article
in Japanese
| MEDLINE | ID: mdl-33790149
12.
Tumor-infiltrating M2 macrophage in pretreatment biopsy sample predicts response to chemotherapy and survival in esophageal cancer.
Cancer Sci
; 111(4): 1103-1112, 2020 Apr.
Article
in English
| MEDLINE | ID: mdl-31981293
13.
First-in-human phase I clinical trial of the NY-ESO-1 protein cancer vaccine with NOD2 and TLR9 stimulants in patients with NY-ESO-1-expressing refractory solid tumors.
Cancer Immunol Immunother
; 69(4): 663-675, 2020 Apr.
Article
in English
| MEDLINE | ID: mdl-31980914
14.
Neoadjuvant Chemotherapy With Anthracycline-Based Regimen for BRCAness Tumors in Triple-Negative Breast Cancer.
J Surg Res
; 250: 143-147, 2020 06.
Article
in English
| MEDLINE | ID: mdl-32044511
15.
The Prospective Studies of Atherosclerosis (Proof-ATHERO) Consortium: Design and Rationale.
Gerontology
; 66(5): 447-459, 2020.
Article
in English
| MEDLINE | ID: mdl-32610336
16.
Therapeutic potential of PLK1 inhibition in triple-negative breast cancer.
Lab Invest
; 99(9): 1275-1286, 2019 09.
Article
in English
| MEDLINE | ID: mdl-30996295
17.
The E3 ligase synoviolin controls body weight and mitochondrial biogenesis through negative regulation of PGC-1ß.
EMBO J
; 34(8): 1042-55, 2015 Apr 15.
Article
in English
| MEDLINE | ID: mdl-25698262
18.
Severe colitis after PD-1 blockade with nivolumab in advanced melanoma patients: potential role of Th1-dominant immune response in immune-related adverse events: two case reports.
BMC Cancer
; 19(1): 1019, 2019 Oct 29.
Article
in English
| MEDLINE | ID: mdl-31664934
19.
Irreversible Electroporation versus Radiofrequency Ablation: Comparison of Systemic Immune Responses in Patients with Hepatocellular Carcinoma.
J Vasc Interv Radiol
; 30(6): 845-853.e6, 2019 Jun.
Article
in English
| MEDLINE | ID: mdl-31126596
20.
Rationale and study design of a clinical trial to assess the effects of LDL apheresis on proteinuria in diabetic patients with severe proteinuria and dyslipidemia.
Clin Exp Nephrol
; 22(3): 591-596, 2018 Jun.
Article
in English
| MEDLINE | ID: mdl-29080119